In this manuscript, we focused on stem cell transcription factors and ABC transporters in TMZ-treated glioma to establish whether CEBPD affects cancer stemness and drug resistance in TMZ-treated glioma. This evidence concerns the gene ABCG2 and central nervous system cancer.